Latest filing published 02 May 2017 for CTI Biopharma CORP.
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Phillip M. Nudelman PhD: trading record in brief
Phillip M. Nudelman PhD is a declared insider of CTI Biopharma Corp, with filings sourced from SEC (Form 4). Between 18 April 2006 and 29 April 2017, the trades on record add up to 169 filings.
In open-market terms, that means 1 purchase worth €9,101 on one side and 140 sales worth €1.0M on the other. Taken together, the sales exceed the purchases by €1.0M. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Other entries cover 23 share grants and 2 option exercises.
Most recently, on 2 May 2017, the filings show an option exercise in CTI Biopharma Corp. The most recent open-market purchase was published on 20 March 2008, 6,807 days ago. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Phillip M. Nudelman PhD
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 39,698 sharesCommon StockSEC:0000899243-17-011487:0
- 79,618 sharesCommon StockSEC:0000891293-16-000154:0
- 87,481 shares0Common StockSEC:0000891293-15-000067:0
- 480 shares@ US$1.45Common StockSEC:0000891293-15-000052:0
- 1,000 shares@ US$1.45Common StockSEC:0000891293-15-000052:1
- 12,900 shares@ US$1.45Common StockSEC:0000891293-15-000052:2
- 135,620 shares@ US$1.45Common StockSEC:0000891293-15-000052:3
- 43,555 shares0Common StockSEC:0000891293-14-000015:0
- 2,250 shares@ US$3.53Common StockSEC:0000891293-14-000007:0
- 4,950 shares@ US$3.54Common StockSEC:0000891293-14-000007:1
- 8,000 shares@ US$3.54Common StockSEC:0000891293-14-000007:2
- 2,000 shares@ US$3.55Common StockSEC:0000891293-14-000007:3
- 13,097 shares@ US$3.55Common StockSEC:0000891293-14-000007:4
- 6,103 shares@ US$3.56Common StockSEC:0000891293-14-000007:5
- 8,200 shares@ US$3.56Common StockSEC:0000891293-14-000007:6
- 6,900 shares@ US$3.57Common StockSEC:0000891293-14-000007:7
- 200 shares@ US$3.57Common StockSEC:0000891293-14-000007:8
- 20,500 shares@ US$3.57Common StockSEC:0000891293-14-000007:9
- 2,900 shares@ US$3.57Common StockSEC:0000891293-14-000007:10
- 21,900 shares@ US$3.58Common StockSEC:0000891293-14-000007:11
- 1,599 shares@ US$3.58Common StockSEC:0000891293-14-000007:12
- 1,301 shares@ US$3.59Common StockSEC:0000891293-14-000007:13
- 100 shares@ US$3.59Common StockSEC:0000891293-14-000007:14
- 219,000 shares0Common StockSEC:0001209191-14-006325:0
- 43,100 shares@ US$1.09Common StockSEC:0000891293-13-000035:0
25 of 168 declarations
